TGFB2 and breast cancer: TGF-β2 and TGFBR3 were found upregulated in dormant basal type DTCs from breast cancer patient-derived xenograft (PDX) studies28, arguing that this pathway might regulate dormancy in multiple tissues and epithelial cancers.